Guifu Dihuang Pills Ameliorated Mucus Hypersecretion by Suppressing Muc5ac Expression and Inactivating the ERK-SP1 Pathway in Lipopolysaccharide/Cigarette Smoke-Induced Mice

Mucus hypersecretion is a hallmark of chronic obstructive pulmonary disease (COPD) and is associated with increasing sputum production and declining pulmonary function. Therefore, reducing mucus secretion can be a new therapeutic opportunity for preventing COPD. The Guifu Dihuang pill (GFDHP) is a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huanhuan, Yu, Wenying, Ji, Liting, Zhong, Yusen, Lin, Yiyou, Ying, Huazhong, Yu, Chenhuan, Li, Changyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580658/
https://www.ncbi.nlm.nih.gov/pubmed/34777538
http://dx.doi.org/10.1155/2021/9539218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580658/
https://www.ncbi.nlm.nih.gov/pubmed/34777538
http://dx.doi.org/10.1155/2021/9539218

Ejemplares similares